About NEURXSTEM, INC
Neurxstem develops patented human brain models capable of generating regulator-grade molecular data for diagnostics, therapeutics, and predictive AI. The platform combines human biology, functional genomics, and high-precision metabolomics, delivering 98% reproducibility and direct concordance with postmortem tissue.
Development of patented neural organoid platforms with complete human brain architectureGeneration of high-precision transcriptomic and metabolomic datasets with 98–99% reproducibilityHuman-validated molecular evidence for Alzheimer’s, Parkinson’s, aging, migraine, autism, and opioid use disorderSupport for early diagnostics, companion biomarkers, and mechanism-of-action validationCreation of AI learning datasets for predictive modeling and digital twinsPatented human progeria-based accelerated aging models for longevity research
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Defense | $50K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NEURXSTEM, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.